One of three MYC family oncogenes, MYC, MYCN or MYCL, is amplified in approximately 20% of SCLCs, with the frequency of MYCL amplification the highest among the MYC family genes in clinical SCLC samples [5-9]. Here, MYCN is linked to small cell lung carcinoma.